Applying Real-World Data and Real-World Evidence for Accelerated Approvals and Coverage Decisions
Executive Summary Medical products granted accelerated approval by the United States Food and Drug Administration (FDA), and the evidence guiding such approvals, have been subject to controversy in recent years. Meanwhile, there is an ongoing need to deliver rapidly effective products to patients with unmet medical needs while also addressing…